KEGG CYSTEINE AND METHIONINE METABOLISM
| 34 | 24 | All SZGR 2.0 genes in this pathway |
KEGG SELENOAMINO ACID METABOLISM
| 26 | 18 | All SZGR 2.0 genes in this pathway |
REACTOME SULFUR AMINO ACID METABOLISM
| 24 | 17 | All SZGR 2.0 genes in this pathway |
REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES
| 200 | 136 | All SZGR 2.0 genes in this pathway |
REACTOME BIOLOGICAL OXIDATIONS
| 139 | 91 | All SZGR 2.0 genes in this pathway |
REACTOME PHASE II CONJUGATION
| 70 | 42 | All SZGR 2.0 genes in this pathway |
DOANE RESPONSE TO ANDROGEN UP
| 184 | 125 | All SZGR 2.0 genes in this pathway |
BORCZUK MALIGNANT MESOTHELIOMA UP
| 305 | 185 | All SZGR 2.0 genes in this pathway |
WANG LMO4 TARGETS UP
| 372 | 227 | All SZGR 2.0 genes in this pathway |
RHEIN ALL GLUCOCORTICOID THERAPY DN
| 362 | 238 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA DN
| 1375 | 806 | All SZGR 2.0 genes in this pathway |
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS UP
| 126 | 72 | All SZGR 2.0 genes in this pathway |
MARKEY RB1 ACUTE LOF DN
| 228 | 137 | All SZGR 2.0 genes in this pathway |
BERENJENO TRANSFORMED BY RHOA UP
| 536 | 340 | All SZGR 2.0 genes in this pathway |
OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP
| 69 | 40 | All SZGR 2.0 genes in this pathway |
SHETH LIVER CANCER VS TXNIP LOSS PAM4
| 261 | 153 | All SZGR 2.0 genes in this pathway |
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP
| 479 | 299 | All SZGR 2.0 genes in this pathway |
PUJANA BRCA1 PCC NETWORK
| 1652 | 1023 | All SZGR 2.0 genes in this pathway |
LOPEZ MBD TARGETS
| 957 | 597 | All SZGR 2.0 genes in this pathway |
GOTZMANN EPITHELIAL TO MESENCHYMAL TRANSITION DN
| 206 | 136 | All SZGR 2.0 genes in this pathway |
MORI EMU MYC LYMPHOMA BY ONSET TIME UP
| 110 | 69 | All SZGR 2.0 genes in this pathway |
BYSTRYKH HEMATOPOIESIS STEM CELL AND BRAIN QTL TRANS
| 185 | 114 | All SZGR 2.0 genes in this pathway |
ZUCCHI METASTASIS UP
| 43 | 24 | All SZGR 2.0 genes in this pathway |
TARTE PLASMA CELL VS PLASMABLAST DN
| 309 | 206 | All SZGR 2.0 genes in this pathway |
SCHUHMACHER MYC TARGETS UP
| 80 | 57 | All SZGR 2.0 genes in this pathway |
SMITH TERT TARGETS DN
| 87 | 69 | All SZGR 2.0 genes in this pathway |
BYSTRYKH HEMATOPOIESIS STEM CELL QTL TRANS
| 882 | 572 | All SZGR 2.0 genes in this pathway |
COLLER MYC TARGETS UP
| 25 | 19 | All SZGR 2.0 genes in this pathway |
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK DN
| 546 | 351 | All SZGR 2.0 genes in this pathway |
BROWN MYELOID CELL DEVELOPMENT DN
| 129 | 86 | All SZGR 2.0 genes in this pathway |
KAMMINGA EZH2 TARGETS
| 41 | 26 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS EARLY PROGENITOR
| 532 | 309 | All SZGR 2.0 genes in this pathway |
RHODES CANCER META SIGNATURE
| 64 | 47 | All SZGR 2.0 genes in this pathway |
PAL PRMT5 TARGETS UP
| 203 | 135 | All SZGR 2.0 genes in this pathway |
JACKSON DNMT1 TARGETS UP
| 77 | 57 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS INTERMEDIATE PROGENITOR
| 149 | 84 | All SZGR 2.0 genes in this pathway |
GAVIN FOXP3 TARGETS CLUSTER T4
| 94 | 69 | All SZGR 2.0 genes in this pathway |
KYNG DNA DAMAGE BY GAMMA AND UV RADIATION
| 88 | 65 | All SZGR 2.0 genes in this pathway |
KYNG DNA DAMAGE UP
| 226 | 164 | All SZGR 2.0 genes in this pathway |
WALLACE PROSTATE CANCER UP
| 20 | 14 | All SZGR 2.0 genes in this pathway |
ACEVEDO NORMAL TISSUE ADJACENT TO LIVER TUMOR DN
| 354 | 216 | All SZGR 2.0 genes in this pathway |
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UP
| 863 | 514 | All SZGR 2.0 genes in this pathway |
MITSIADES RESPONSE TO APLIDIN DN
| 249 | 165 | All SZGR 2.0 genes in this pathway |
ZHANG BREAST CANCER PROGENITORS UP
| 425 | 253 | All SZGR 2.0 genes in this pathway |
BOCHKIS FOXA2 TARGETS
| 425 | 261 | All SZGR 2.0 genes in this pathway |
GRADE COLON AND RECTAL CANCER UP
| 285 | 167 | All SZGR 2.0 genes in this pathway |
CHEN METABOLIC SYNDROM NETWORK
| 1210 | 725 | All SZGR 2.0 genes in this pathway |
SHAFFER IRF4 TARGETS IN MYELOMA VS MATURE B LYMPHOCYTE
| 101 | 76 | All SZGR 2.0 genes in this pathway |
SHAFFER IRF4 TARGETS IN ACTIVATED B LYMPHOCYTE
| 81 | 66 | All SZGR 2.0 genes in this pathway |
CHEOK RESPONSE TO MERCAPTOPURINE AND HD MTX DN
| 25 | 18 | All SZGR 2.0 genes in this pathway |
IRITANI MAD1 TARGETS DN
| 47 | 30 | All SZGR 2.0 genes in this pathway |
YAMASHITA LIVER CANCER WITH EPCAM UP
| 53 | 25 | All SZGR 2.0 genes in this pathway |
HOSHIDA LIVER CANCER SUBCLASS S2
| 115 | 74 | All SZGR 2.0 genes in this pathway |
CAIRO HEPATOBLASTOMA CLASSES UP
| 605 | 377 | All SZGR 2.0 genes in this pathway |
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 12
| 79 | 54 | All SZGR 2.0 genes in this pathway |
KIM ALL DISORDERS OLIGODENDROCYTE NUMBER CORR UP
| 756 | 494 | All SZGR 2.0 genes in this pathway |
KIM BIPOLAR DISORDER OLIGODENDROCYTE DENSITY CORR UP
| 682 | 440 | All SZGR 2.0 genes in this pathway |
KIM ALL DISORDERS CALB1 CORR UP
| 548 | 370 | All SZGR 2.0 genes in this pathway |
BILANGES SERUM SENSITIVE GENES
| 90 | 54 | All SZGR 2.0 genes in this pathway |
BILANGES RAPAMYCIN SENSITIVE VIA TSC1 AND TSC2
| 73 | 37 | All SZGR 2.0 genes in this pathway |
VANOEVELEN MYOGENESIS SIN3A TARGETS
| 220 | 133 | All SZGR 2.0 genes in this pathway |